Corporate Banner
Satellite Banner
Automation & Microfluidics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Microfluidics Market Expected to Grow at a CAGR 17.6% to 2018

Published: Thursday, January 09, 2014
Last Updated: Thursday, January 09, 2014
Bookmark and Share
The high growth in this market can be attributed to the rising demand for point of care devices.

Research and Markets announced the addition of the "Microfluidics Market By Materials, Pharmaceuticals, Drug Delivery Devices, IVD - Global Trends & Forecast to 2018" report to their offering.

The global microfluidics market is valued at an estimated $1.59 billion in 2013 and is expected to grow at a CAGR of 17.6% in the next five years. The high growth in this market can be attributed to the rising demand for POC devices, quick return on investments provided by microfluidics devices which helps in cost reduction, and miniaturization of microfluidic chips.

The market is categorized into materials, products, and application segments. This report studies market estimations and trends for the above mentioned segments in three industries, namely, pharmaceutical, in-vitro diagnostics, and drug delivery devices. Factors such as the difficulty in incorporating emerging microfluidic technologies into existing workflows, and the complex and time consuming regulatory standards are hampering the growth of this market.

The market is expected to witness a high growth in the drug delivery devices segment, as these devices offer effective solutions for enhanced drug delivery through inhaler nozzles, micropumps, and micro needles. The micropumps market within the drug delivery devices segment is estimated to grow at the highest CAGR from 2013 to 2018; enhanced applications such as precise fluid control in nano and micro liter range are driving the growth of this market.

According to industry experts, the number of patent applications for microfluidics technology has increased from approximately 300 per year to around 4,000 per year. This increase in patent filings not only indicates the rising adoption of microfluidics technology across several applications but also the future opportunities in the competitive environment to capitalize the technology. Significant breakthroughs in nucleic acid analysis such as Human Genome project (HGP), and enhanced efficacy in applications such as drug discovery and Point-of-Care diagnosis are resulting in new patent filings.

North America accounts for the largest share of the global market, followed by Europe. However, Asia is expected to grow at the highest CAGR during the study period.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Paving the way to Better Ovarian Cancer Diagnosis
Aïcha BenTaieb will present her invention for automated identification of ovarian cancer’s many subtypes at an international conference this fall.
New Tech Enables Epigenomic Analysis with a Mere 100 Cells
A new technology that will dramatically enhance investigations of epigenomes, the machinery that turns on and off genes and a very prominent field of study in diseases such as stem cell differentiation, inflammation and cancer has been developed by researchers at Virginia Tech.
Futuristic Brain Probe Allows for Wireless Control of Neurons
NIH-funded scientists developed an ultra-thin, minimally invasive device for controlling brain cells with drugs and light.
Microfluidic Device Mixes And Matches DNA For Synthetic Biology
Researchers have developed a microfluidic device that quickly builds packages of DNA and delivers them into bacteria or yeast for further testing.
Artificial Pancreas Controls Diabetes
Scientists are reporting the development of an implantable “artificial pancreas” that continuously measures a person’s blood sugar, or glucose, level and can automatically release insulin as needed.
Major Step for Implantable Drug-Delivery Device
MIT spinout signs deal to commercialize microchips that release therapeutics inside the body.
Smart Insulin Patch Could Replace Painful Injections for Diabetes
A joint effort between diabetes doctors and biomedical engineers could revolutionize how people with diabetes keep their blood sugar levels in check.
The Secrets of Secretion
Researchers have hacked nature's blueprints to create a new technology that could have broad-reaching impact on drug delivery systems and self-healing and anti-fouling materials.
New Tool on Horizon for Surgeons Treating Cancer Patients
Surgeons could know while their patients are still on the operating table if a tissue is cancerous, according to researchers.
Heartbeat on a Chip Could Improve Pharmaceutical Tests
A gravity-powered chip that can mimic a human heartbeat outside the body could advance pharmaceutical testing and open new possibilities in cell culture because it can mimic fundamental physical rhythms.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!